Making life science life changing
We help promising scientific ideas reach the next phase of development through investment, partnerships and expertise for health conditions that need it most.
Scientific expertise
30 years of experience in antibody humanisation, diagnostics and biomarker development, and drug development.
Funding and investment
See our open funding calls or learn more about how we invest in early-stage ventures.
Intellectual property and tech transfer
Help with licensing and collaborative development, at a lower risk to you.
Partner with us
We can work together to connect you with the right support for your project – partner with us.
Our Translational Challenges
Motor Neuron Disease
Our vision is a world where motor neuron disease is preventable and treatable.
Chronic Respiratory Infection
Our vision is improved quality of life for those living with cystic fibrosis and bronchiectasis.
Global Health
Our vision is a world with affordable and accessible solutions to better understand, treat, and prevent infectious diseases.
Rare Disease
Our vision is an ecosystem working together to get discoveries and treatments to rare disease patients faster.
Childhood Cancer
Our vision is to drive life-changing innovations for children with cancer.
What’s happening at LifeArc
Our work in neurodegeneration
We’re working to improve prediction and diagnosis of neurodegenerative conditions.
2023 annual review
Read about the projects and initiatives that made 2023 at LifeArc such an eventful and successful year.
We’re hiring!
We’re looking for talented people to join the LifeArc team.
Case studies
See how we’ve partnered to progress promising life science.
MND drug repurposing call
A new £5 million programme to help find new treatments for motor neuron disease.
Latest news
-
Charities join forces to transform treatment for children with cancer
Read more: Charities join forces to transform treatment for children with cancer -
AI software tool aims to spot early signs of dementia from brain scans during routine appointments
Read more: AI software tool aims to spot early signs of dementia from brain scans during routine appointments -
Raising awareness of NTM pulmonary disease and its new Standards of Care
Read more: Raising awareness of NTM pulmonary disease and its new Standards of Care